Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I3 | Q14994 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
| ▸ | MBOAT4 | Q96T53 | 2/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.33 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5575242 | 0.81 | ESR1 (0.31) | ESR1ARESR2 | |
| SCHEMBL5570855 | 0.81 | CYP19A1 (0.38) | NR1I3CYP19A1SHBGMBOAT4 | |
| SCHEMBL5311967 | 0.81 | NR1I3 (0.39) | NR1I3CYP19A1SHBGMBOAT4CDK5 | |
| SCHEMBL5570856 | 0.79 | CYP19A1 (0.43) | NR1I3CYP19A1SHBGMBOAT4ESR1 | |
| SCHEMBL1963780 | 0.73 | ESR1 (0.49) | CYP19A1SHBGESR1ARESR2 | |
| SCHEMBL1419457 | 0.73 | CYP19A1 (0.43) | CYP19A1SHBGMBOAT4 | |
| SCHEMBL10455662 | 0.73 | CYP19A1 (0.40) | CYP19A1SHBGMBOAT4 | |
| SCHEMBL8585530 | 0.72 | CYP19A1 (0.35) | NR1I3CYP19A1SHBGMBOAT4CDK5 | |
| SCHEMBL5310137 | 0.72 | CYP19A1 (0.36) | NR1I3CYP19A1SHBGMBOAT4CDK5 | |
| SCHEMBL4308160 | 0.72 | SHBG (0.39) | CYP19A1SHBGMBOAT4ESR1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1807118-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | Hollis-Eden Pharmaceuticals Inc. (US) | 2007-07-18 | — | — | EP | disclosed |
| WO-2006110172-A2 | STEROID ANALOGS AND CHARACTERIZATION AND TREATMENT METHODS | HOLLIS-EDEN PHARMACEUTICALS.INC. (US) | 2006-10-19 | — | — | WO | disclosed |